Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

I & L Biosystems Nordic A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.7% 2.7%   Bankruptcy risk   12.9% 10.7% 22.4% 25.7% 3.7% 2.3% 9.7% 9.5%   Credit score (0-100)   19 24 4 2 51 63 25 26   Credit rating   BB BB B B BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 -0.0 -0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   364 780 355 328 4,740 1,711 0.0 0.0   EBITDA   -364 52.0 -620 -755 3,923 531 0.0 0.0   EBIT   -364 52.0 -620 -755 3,923 531 0.0 0.0   Pre-tax profit (PTP)   -379.0 42.0 -641.0 -749.0 3,878.0 450.5 0.0 0.0   Net earnings   -394.0 42.0 -641.0 -749.0 3,429.0 346.4 0.0 0.0   Pre-tax profit without non-rec. items   -379 42.0 -641 -749 3,878 451 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -66.0 -24.0 -665 -1,415 2,014 2,360 1,860 1,860   Interest-bearing liabilities   524 704 580 1,247 0.0 1,424 0.0 0.0   Balance sheet total (assets)   1,550 2,293 1,860 2,101 4,919 5,961 1,860 1,860   Net Debt   -127 -147 -244 311 -693 1,197 -1,860 -1,860     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   364 780 355 328 4,740 1,711 0.0 0.0   Gross profit growth   0.0% 114.3% -54.5% -7.6% 1,345.1% -63.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,550 2,293 1,860 2,101 4,919 5,961 1,860 1,860   Balance sheet change%   186.0% 47.9% -18.9% 13.0% 134.1% 21.2% -68.8% 0.0%   Added value   -364.0 52.0 -620.0 -755.0 3,923.0 531.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -100.0% 6.7% -174.6% -230.2% 82.8% 31.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -33.7% 2.6% -25.6% -25.0% 93.0% 9.9% 0.0% 0.0%   ROI %   -69.6% 8.5% -96.6% -82.6% 240.6% 18.5% 0.0% 0.0%   ROE %   -42.0% 2.2% -30.9% -37.8% 166.7% 15.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -4.1% -1.1% -26.3% -40.2% 40.9% 39.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   34.9% -282.7% 39.4% -41.2% -17.7% 225.3% 0.0% 0.0%   Gearing %   -793.9% -2,933.3% -87.2% -88.1% 0.0% 60.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.2% 1.6% 3.3% -0.7% 7.2% 12.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 1.0 0.6 0.5 1.6 1.6 0.0 0.0   Current Ratio   0.9 1.0 0.7 0.6 1.7 1.7 0.0 0.0   Cash and cash equivalent   651.0 851.0 824.0 936.0 693.0 227.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -85.0 -44.0 -685.0 -1,435.0 1,994.0 2,340.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -364 52 -620 -755 3,923 531 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -364 52 -620 -755 3,923 531 0 0   EBIT / employee   -364 52 -620 -755 3,923 531 0 0   Net earnings / employee   -394 42 -641 -749 3,429 346 0 0